NEO
Price
$10.28
Change
+$0.19 (+1.88%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
2.01B
4 days until earnings call
SERA
Price
$3.15
Change
-$0.21 (-6.27%)
Updated
Apr 25, 04:36 PM (EDT)
Capitalization
303.83M
12 days until earnings call
Ad is loading...

NEO vs SERA

Header iconNEO vs SERA Comparison
Open Charts NEO vs SERABanner chart's image
NeoGenomics
Price$10.28
Change+$0.19 (+1.88%)
Volume$24.69K
Capitalization2.01B
Sera Prognostics
Price$3.15
Change-$0.21 (-6.27%)
Volume$200
Capitalization303.83M
NEO vs SERA Comparison Chart
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. SERA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Buy and SERA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (NEO: $10.09 vs. SERA: $3.35)
Brand notoriety: NEO and SERA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 121% vs. SERA: 102%
Market capitalization -- NEO: $2.01B vs. SERA: $303.83M
NEO [@Medical Specialties] is valued at $2.01B. SERA’s [@Medical Specialties] market capitalization is $303.83M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileSERA’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • SERA’s FA Score: 0 green, 5 red.
According to our system of comparison, SERA is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 5 TA indicator(s) are bullish while SERA’s TA Score has 5 bullish TA indicator(s).

  • NEO’s TA Score: 5 bullish, 3 bearish.
  • SERA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both NEO and SERA are a good buy in the short-term.

Price Growth

NEO (@Medical Specialties) experienced а +5.65% price change this week, while SERA (@Medical Specialties) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.14%. For the same industry, the average monthly price growth was -4.28%, and the average quarterly price growth was -1.93%.

Reported Earning Dates

NEO is expected to report earnings on Jul 30, 2025.

SERA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+5.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than SERA($304M). NEO YTD gains are higher at: -38.774 vs. SERA (-58.845). NEO has higher annual earnings (EBITDA): -17.61M vs. SERA (-35.29M). NEO has more cash in the bank: 415M vs. SERA (49.1M). SERA has less debt than NEO: SERA (1.86M) vs NEO (612M). NEO has higher revenues than SERA: NEO (592M) vs SERA (306K).
NEOSERANEO / SERA
Capitalization2.01B304M660%
EBITDA-17.61M-35.29M50%
Gain YTD-38.774-58.84566%
P/E Ratio49.50N/A-
Revenue592M306K193,464%
Total Cash415M49.1M845%
Total Debt612M1.86M32,939%
FUNDAMENTALS RATINGS
NEO: Fundamental Ratings
NEO
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEOSERA
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 25 days ago
81%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIIMX20.82N/A
N/A
Fidelity Advisor Mid Cap II I
INFIX8.76N/A
N/A
Tortoise Energy Infras and Inc Ins
LGLUX42.55N/A
N/A
Lord Abbett Growth Leaders R5
BUIDX30.11N/A
N/A
Buffalo Growth & Income Inst
FAPNX12.30N/A
N/A
Fidelity Advisor Healthy Future Z